Cargando…
Obesity Paradox in Atrial Fibrillation and its Relation with the New Oral Anticoagulants
Obesity, a chronic disease established as a global epidemic by the World Health Organization, is considered a risk factor for atrial fibrillation (AF), the most common sustained cardiac arrhythmia, which has high morbidity and mortality. Although both obesity and AF are diseases associated with nega...
Autores principales: | Filho, André Inocêncio Novaes Lima, do Rego Barros, Mariana Costa, de Barros Guimarães, Alice Almeida, Filho, Dário Celestino Sobral |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896420/ https://www.ncbi.nlm.nih.gov/pubmed/35331095 http://dx.doi.org/10.2174/1573403X18666220324111343 |
Ejemplares similares
-
The complication of left internal jugular vein
puncture
por: Ferreira Gomes, Rafael Alessandro, et al.
Publicado: (2021) -
Acute Mesenteric Ischemia in a Chronically Anticoagulated Patient With Atrial Fibrillation: Anticoagulation Reversal, Management and Preventing Recurrence
por: Aziz, Ahmed Ali, et al.
Publicado: (2022) -
Use of Anticoagulants in Patients With Non-Valvular Atrial Fibrillation Who Are at Risk of Falls
por: Shanah, Layla, et al.
Publicado: (2020) -
Efficacy and Safety of Direct Oral Anticoagulant for Treatment of Atrial Fibrillation in Cerebral Amyloid Angiopathy
por: Narita, Koichi, et al.
Publicado: (2020) -
Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department
por: Akman, Canan, et al.
Publicado: (2021)